Helix Biopharm (HBP.TO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 07/31
| 01-2022 | 10-2021 | 07-2021 | 04-2021 | 01-2021 | |
| Operating Expenses | 1,926 | 1,696 | 2,256 | 2,584 | 1,904 |
| Operating Income | -1,926 | -1,696 | -2,256 | -2,584 | -1,904 |
| Interest Expense | 9 | 3 | 4 | 3 | 4 |
| Other Income | -84 | -114 | -510 | 33 | 42 |
| Pre-tax Income | -2,019 | -1,813 | -2,770 | -2,554 | -1,866 |
| Net Income Continuous | -2,019 | -1,813 | -2,770 | -2,554 | -1,866 |
| Net Income Discontinuous | 0 | 0 | 0 | 0 | -626 |
| Net Income | $-2,019 | $-1,813 | $-2,770 | $-2,554 | $-2,492 |
| EPS Basic Total Ops | -0.05 | -0.05 | -0.10 | -0.10 | -0.10 |
| EPS Basic Continuous Ops | -0.05 | -0.05 | -0.10 | -0.10 | -0.10 |
| EPS Diluted Total Ops | -0.05 | -0.05 | -0.10 | -0.10 | -0.10 |
| EPS Diluted Continuous Ops | -0.05 | -0.05 | -0.10 | -0.10 | -0.10 |
| EBITDA(a) | $-2,007 | $-1,807 | $-2,704 | $-2,511 | $-1,841 |